[HSF] Fwd: STS MEMBER ALERT: FDA Issues Statement on Use ofAprotinin (Tra...

Ben Bidstrup benjamin.bidstrup at bigpond.com
Sun Oct 28 11:54:23 EDT 2007


>Claudia,
>   It may be a "nice" drug, but it sure is getting an increasingly  dangerous
>reputation.  The FDA site is _http://www.fda.gov/cder/drug/early_
>(http://www.fda.gov/cder/drug/early)   comm/aprotinin.htm.  Members 
>should know that I've
>got absolutely no  financial interest one way or the other in regards to
>aprotinin.  However,  I believe its use should be limited to 
>dialysis patients or
>patients undergoing  major aortic reconstructions.
>
>Hal
>
Before one goes to town and draws conclusions, the details of the 
reasons for stopping (approaching significance) and the analysis of 
the data which will take 6-8 weeks must be awaited.

-- 
Ben Bidstrup FRACS FRCSEd FEBCTS
Consultant Cardiothoracic Surgeon


More information about the OpenHeart-L mailing list